Seo Kyung Won, Kim Kyu Bong, Kim Yun Jung, Choi Ju Young, Lee Kyung Tae, Choi Kwang Sik
Toxicology Department, National Institute of Toxicological Research, Korea Food and Drug Administration, 5 Nokbundong, Eunpyunggu, Seoul 122-704, South Korea.
Food Chem Toxicol. 2004 Jan;42(1):107-14. doi: 10.1016/j.fct.2003.08.010.
Phthalates are widely used as a plasticizer and cause a peroxisome proliferation. Peroxisome proliferators (PPs), such as di-2-ethylhexyl phthalate (DEHP) and clofibrate (CF) are known to have a hepatocarcinogenic potential in rodents. It has been proposed that these PPs may cause hepatocellular cancer by an oxidative damage-mediated mechanism(s). The primary purpose of this study is to find whether there is a difference between the oxidative damage by hepatocarcinogenic PPs (DEHP and CF) and the oxidative damage by weak PPs [di-n-butyl phthalate (DBP) and n-butylbenzyl phthalate (BBP)]. The second purpose is to investigate if phthalates can affect the phase I/phase II enzymes, and if the effect of PPs on metabolizing enzymes correlates with peroxisome proliferation or not. After rats were treated with PPs (DEHP, DBP and BBP; 50, 200, 1000 mg/kg, CF; 100 mg/kg, p.o., for 14 days), the activities of metabolizing enzymes and peroxisomal enzymes were investigated, and the oxidative damage was measured using 8-hydroxydeoxyguanosine (8-OHdG) in the DNA and malonedialdehyde (MDA) in the livers. These four PPs significantly increased the relative liver weights, palmitoyl-CoA oxidation and activity of carnitine acetyltransferase. DEHP was found to be the most potent PP among three phthalates. A dramatic and dose-dependent increase in hepatic MDA levels was observed in CF (100 mg/kg), DEHP (>or=50 mg/kg), DBP and BBP (>or=200 mg/kg) groups. However, the 8-OHdG in hepatic DNA was increased only in DEHP (1000 mg/kg) and CF groups. Activities of cytochrome p4501A1, 1A2, 3A4, UDP-glucuronosyl transferase and glutathione S-transferase were decreased overall by PPs, but there is no correlation between the inhibitory effect on metabolizing enzymes and the peroxisome proliferation. These results indicate that 8-OHdG positively correlates with carcinogenic potential of PPs, but other factors as well as peroxisomal H(2)O(2) could be involved in the generation of 8-OHdG and the carcinogenesis of PPs. The present findings also demonstrate that the effect of PPs on xenobiotic metabolizing enzymes may be independent of the peroxisome proliferation and the oxidative stress. Thus it is possible that the PPs affect the hepatic toxification/detoxification capacity even in humans.
邻苯二甲酸盐被广泛用作增塑剂,并会导致过氧化物酶体增殖。已知过氧化物酶体增殖剂(PPs),如邻苯二甲酸二(2-乙基己基)酯(DEHP)和氯贝丁酯(CF)在啮齿动物中具有潜在的致癌性。有人提出,这些PPs可能通过氧化损伤介导的机制导致肝细胞癌。本研究的主要目的是找出致癌性PPs(DEHP和CF)引起的氧化损伤与弱PPs[邻苯二甲酸二正丁酯(DBP)和邻苯二甲酸丁苄酯(BBP)]引起的氧化损伤之间是否存在差异。第二个目的是研究邻苯二甲酸盐是否会影响I相/II相酶,以及PPs对代谢酶的影响是否与过氧化物酶体增殖相关。在用PPs(DEHP、DBP和BBP;50、200、1000mg/kg,CF;100mg/kg,口服,持续14天)处理大鼠后,研究了代谢酶和过氧化物酶体酶的活性,并使用肝脏DNA中的8-羟基脱氧鸟苷(8-OHdG)和丙二醛(MDA)测量氧化损伤。这四种PPs均显著增加了肝脏相对重量、棕榈酰辅酶A氧化和肉碱乙酰转移酶活性。在三种邻苯二甲酸盐中,DEHP被发现是最有效的PP。在CF(100mg/kg)、DEHP(≥50mg/kg)、DBP和BBP(≥200mg/kg)组中观察到肝脏MDA水平显著且呈剂量依赖性增加。然而,仅在DEHP(1000mg/kg)和CF组中肝脏DNA中的8-OHdG增加。PPs总体上降低了细胞色素p4501A1、1A2、3A4、尿苷二磷酸葡萄糖醛酸转移酶和谷胱甘肽S-转移酶的活性,但对代谢酶的抑制作用与过氧化物酶体增殖之间没有相关性。这些结果表明,8-OHdG与PPs的致癌潜力呈正相关,但8-OHdG的产生和PPs的致癌作用可能还涉及其他因素以及过氧化物酶体H2O2。目前的研究结果还表明,PPs对异源生物代谢酶的影响可能独立于过氧化物酶体增殖和氧化应激。因此,即使在人类中,PPs也有可能影响肝脏的解毒/排毒能力。